“showed a trend”

Prophylactic use of rituximab showed a trend toward better overall survival both in Kaplan-Meier analysis (p=0.0717) ( Figure 1H ) and the Cox model (HR=0.66; 95%CI=0.43-1.03; p=0.0687).

Additionally, the presence of peritoneal dissemination showed a trend toward lower odds of TCS (OR, 0.27; 95% CI: 0.067-1.12; P= 0.0718) ( Table 5 ).

The gene expression of CTSK showed a trend toward a positive correlation with the IC50 value ( p = 0.0719; Fig. 5 A ).

Pyloroplasty showed a trend towards better emptying ( p = 0.0719) with more patients achieving ≥ 50% improvement (70.3% vs. 50%, p = 0.086).

In multivariable Cox regression analysis adjusting for age, sex, CCI, LVEF, and AVA (Table 3 ), grade 3 AI‐enabled electrocardiography DD was independently associated with increased mortality risk (HR, 1.80 [95% CI, 1.47–2.20]; P <0.001), whereas moderate DD (grade 2) showed a trend toward higher risk (HR, 1.19 [95% CI, 0.99–1.43]; P =0.072).

In addition, age ≥90 y showed a trend toward association with the occurrence of postoperative complications (OR: 1.64, 95% CI: 0.96–2.80, p = 0.072).

Adults’ performance showed a trend for improved responses on reward compared with neutral trials ( t (15) = 1.939, P = 0.072).

The 2-year cumulative incidence of severe cGVHD in the ATG/PTCy group showed a trend toward decrease compared to that in the ATG group (6.3% vs. 28.4%, P = 0.072).

Higher BMI showed a trend toward a lower detection rate (OR 0.91, 95 % CI 0.82–1.01, P = 0.072).

Moreover, GW274150 has recently been evaluated in a phase IIa clinical trial for early RA, in which the drug showed a trend toward reduction in synovial thickness (33 %; p = 0.072) and synovial vascularity (42 %; p = 0.075) vs. placebo [ 55 ].

With the smaller number of subjects used in this study (7 or 8 per treatment group), hypothermic pups showed a trend for lower MRI scores compared to normothermic pups at 3 h (Mann–Whitney U -test, p = 0.072), and this difference became significant at 7 days (Mann–Whitney U -test, p < 0.05).

Patients who underwent surgical resection showed a trend toward improved survival compared with those diagnosed by biopsy alone (Cox regression HR 0.498, 95% CI: 0.233–1.065, P = 0.072; log-rank test, P = 0.058).

Although not statistically significant, GTR also showed a trend toward greater radiographic bone fill compared to GBR (78.5% vs. 75.2%, P = 0.072).

For somatic pain, the interaction effect only showed a trend towards a significant difference (F(1,89) = 3.31, p = 0.072), and post-hoc tests of change only survived FDR correction in the discontinuation group.

Food and pharmacological allergies or hypersensitivities showed a trend towards statistical significance, being more frequent among patients with DAO deficiency than in those without DAO deficiency (21.7% vs. 6.9%, p = 0.072).

BCAN mRNA levels showed a trend towards increased expression in SZ that did not reach conventional significance level ( p = 0.072, Mann–Whitney U test). 4.

Correlation with clinical parameters No significant associations were observed between serum VEGF-D levels and clinical parameters; however, serum VEGF-D showed a trend toward a weak correlation with DLCO ( r = −0.292, p = 0.072), and resting ( r = −0.397, p = 0.083) and lowest SpO 2 during the 6MWT ( r = −0.394, p = 0.086; Figure 3 and Supplemental Table S3 ).

Low V̇O 2 –High VAT young adult males and females showed a trend toward an increase of production of TNF‐α ( p ‐value = 0.072, p ‐value adjusted 1 = 0.096, and p ‐value adjusted 2 = 0.536) compared with the absence of LPS.

This medication showed a trend for risks to cataract (HR = 1.90, p = 0,072), tear film insufficiency (HR = 2.65, p = 0.071) in the survival analyses, which require further validation in both short-term and long-term prospective trials.

In contrast, CD3 − CD8 + cells were significantly elevated in Her2 − patients (p = 0.017), and Her2 + patients showed a trend toward increased CD3 + CD4 − CD8 − cells (p = 0.072).

Regarding treatment and response, nCRT with TRG 0–1 showed a trend toward improved DFS compared with direct surgery (HR, 0.56; 95% CI, 0.29–1.06; P = 0.072), while nCRT with TRG 2 or TRG 3 did not significantly influence DFS.

Lesion load of inferior cerebellar peduncles showed a significant partial correlation with left regional mean KCC ( p = 0.029), and lesion load of superior cerebellar peduncle showed a trend towards a partial correlation with right cerebellar regional mean KCC ( p = 0.072).

DI scores also showed a trend toward worsening of memory functions in PIO-treated male WT mice ( Figure 2 , P =0.072).

BB users showed a trend towards improved OS (HR 0.50, 95% CI 0.27–1.07; p = 0.072) (Fig. 2 c), with a median OS that was not reached and a 3-year survival of 58% versus a median OS of 34 months and a 3-year survival of 49% in BB non-users.

While the control group showed a trend toward younger age (p=0.072, Table 1 ), this difference was not statistically significant, and all participants were within the same adult age range with no known oral or systemic conditions that would independently affect oral microbiota.